ES2125678T3 - Resorcion transdermal de sustancias activas de masas fundidas subenfriadas. - Google Patents
Resorcion transdermal de sustancias activas de masas fundidas subenfriadas.Info
- Publication number
- ES2125678T3 ES2125678T3 ES95942687T ES95942687T ES2125678T3 ES 2125678 T3 ES2125678 T3 ES 2125678T3 ES 95942687 T ES95942687 T ES 95942687T ES 95942687 T ES95942687 T ES 95942687T ES 2125678 T3 ES2125678 T3 ES 2125678T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- active substances
- resorption
- transdermal
- masses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Abstract
UN MEDICAMENTO QUE DESPRENDE SUSTANCIAS FARMACOLOGICAS A TRAVES DE LA PIEL CON ADYUVANTES QUE ELEVAN LA REABSORCION, Y QUE SE CARACTERIZA PORQUE EL ADYUVANTE FORMA SUSTANCIAS FUNDIDAS SUPERENFRIADAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4446600A DE4446600A1 (de) | 1994-12-24 | 1994-12-24 | Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2125678T3 true ES2125678T3 (es) | 1999-03-01 |
Family
ID=6537122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95942687T Expired - Lifetime ES2125678T3 (es) | 1994-12-24 | 1995-12-18 | Resorcion transdermal de sustancias activas de masas fundidas subenfriadas. |
Country Status (12)
Country | Link |
---|---|
US (1) | US6264980B1 (es) |
EP (1) | EP0792145B1 (es) |
JP (1) | JP3549207B2 (es) |
AT (1) | ATE172640T1 (es) |
AU (1) | AU4387196A (es) |
DE (2) | DE4446600A1 (es) |
DK (1) | DK0792145T3 (es) |
ES (1) | ES2125678T3 (es) |
IL (1) | IL116452A0 (es) |
SI (1) | SI0792145T1 (es) |
WO (1) | WO1996019975A1 (es) |
ZA (1) | ZA9510876B (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
PL357158A1 (en) | 2000-02-08 | 2004-07-12 | Euro-Celtique, S.A. | Controlled-release compositions containing opioid agonist and antagonist |
JP4659943B2 (ja) | 2000-02-25 | 2011-03-30 | 帝三製薬株式会社 | 塩酸ブプレノルフィン含有貼付剤 |
DE60141596D1 (de) | 2000-10-23 | 2010-04-29 | Euro Celtique Sa | Transdermales system zur verabreichung von loratadin und dessen verwendung |
US7018649B2 (en) | 2000-10-23 | 2006-03-28 | Euro-Celtique, S.A. | Felodipine transdermal device and methods |
EP1323421A1 (en) * | 2001-12-20 | 2003-07-02 | Grünenthal GmbH | Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence |
JP2004525960A (ja) * | 2001-02-16 | 2004-08-26 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 尿失禁、特に切迫尿失禁の治療用経皮デリバリーディバイスの製造にブプレノルフィンを使用する方法 |
PL204638B1 (pl) * | 2001-02-16 | 2010-01-29 | Gruenenthal Gmbh | Zastosowanie buprenorfiny do wytwarzania środka leczniczego do leczenia nietrzymania moczu |
KR20100055542A (ko) | 2002-06-25 | 2010-05-26 | 애크럭스 디디에스 피티와이 리미티드 | 비정질 약학적 조성물을 이용한 경피전달속도의 제어 |
US20050191340A1 (en) * | 2002-08-09 | 2005-09-01 | Gruenenthal Gmbh | Opioid-receptor antagonists in transdermal systems having buprenorphine |
ATE444296T1 (de) | 2002-10-25 | 2009-10-15 | Euro Celtique Sa | Analoga und prodrugs von buprenorphin |
DE10305137A1 (de) * | 2003-02-07 | 2004-08-26 | Novosis Ag | Transdermale therapeutische Abgabesysteme mit einem Butenolid |
ME02661B (me) | 2004-02-23 | 2017-06-20 | Euro Celtique Sa | Opioidni transdermalni preparat otporan na zloupotrebu |
EP1743638A1 (en) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical formulations of substituted pyrazoline compounds |
CN103550136B (zh) * | 2006-07-21 | 2016-04-13 | 生物递送科学国际公司 | 吸收增强的经粘膜递送装置 |
DE102006054732B4 (de) | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren |
DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
WO2011130455A1 (en) | 2010-04-13 | 2011-10-20 | Najib Babul | Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use |
ES2528650T3 (es) | 2010-11-17 | 2015-02-11 | Hexal Ag | Sistema terapéutico transdérmico que comprende buprenorfina |
DE102011076653A1 (de) | 2011-05-27 | 2012-11-29 | Acino Ag | Transdermales therapeutisches System enthaltend Buprenorphin und eine alpha-Hydroxysäure |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
JP6289378B2 (ja) | 2011-12-12 | 2018-03-07 | エルテーエス ローマン テラピー−ジステーメ アーゲー | ブプレノルフィンを含む経皮送達システム |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
CA2882870C (en) * | 2012-08-24 | 2020-12-15 | Integurx Therapeutics, Llc | Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
ES2613721T3 (es) * | 2012-12-21 | 2017-05-25 | Teikoku Pharma Usa, Inc. | Composiciones y métodos para administración transdérmica de hormonas y otros agentes medicinales |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11547676B2 (en) | 2012-12-28 | 2023-01-10 | Teikoku Seiyaku Co., Ltd. | Extended buprenorphine transdermal delivery compositions and methods for using the same |
MA38698B1 (fr) | 2013-06-04 | 2017-10-31 | Lts Lohmann Therapie Systeme Ag | Système d'administration transdermique |
JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然の併用ホルモン補充療法剤及び療法 |
DE102014013448A1 (de) | 2014-09-16 | 2016-03-17 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales Therapeutisches System umfassend Buprenorphin |
US9656441B2 (en) | 2015-01-08 | 2017-05-23 | Alfred E. Tiefenbacher ( Gmbh & Co. Kg) | Transdermal patch |
SG11201707350TA (en) | 2015-03-10 | 2017-10-30 | Rhodes Tech | Acetate salt of buprenorphine and methods for preparing buprenorphine |
EP3067050A1 (en) | 2015-03-13 | 2016-09-14 | Acino AG | Transdermal therapeutic system with an overtape comprising two adhesive layers |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
AR102214A1 (es) | 2015-10-08 | 2017-02-15 | Amarin Tech S A | Un dispositivo para la administración transdermal de buprenorfina |
KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598122A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US4900730A (en) * | 1981-01-14 | 1990-02-13 | Toyo Jozo Co., Ltd. | Preparation which promotes the absorption of peptides |
JPS58124711A (ja) * | 1982-01-21 | 1983-07-25 | Kanebo Ltd | 皮膚化粧料 |
DE3315272C2 (de) | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
CA2002299A1 (en) * | 1988-11-10 | 1990-05-10 | Eugene G. Drust | Compositions for the transdermal delivery of buprenorphine salts |
GB8921710D0 (en) * | 1989-09-26 | 1989-11-08 | Mentholatum Co Ltd | Ibuprofen triturates and topical compositions containing same |
US5240711A (en) * | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
DE3939376C1 (es) * | 1989-11-29 | 1991-05-08 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De | |
US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
DE4238223C1 (de) * | 1992-11-12 | 1994-05-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung |
-
1994
- 1994-12-24 DE DE4446600A patent/DE4446600A1/de not_active Withdrawn
-
1995
- 1995-12-18 ES ES95942687T patent/ES2125678T3/es not_active Expired - Lifetime
- 1995-12-18 DK DK95942687T patent/DK0792145T3/da active
- 1995-12-18 US US08/860,961 patent/US6264980B1/en not_active Expired - Lifetime
- 1995-12-18 WO PCT/EP1995/005006 patent/WO1996019975A1/de active IP Right Grant
- 1995-12-18 SI SI9530197T patent/SI0792145T1/xx unknown
- 1995-12-18 AT AT95942687T patent/ATE172640T1/de active
- 1995-12-18 JP JP52018096A patent/JP3549207B2/ja not_active Expired - Lifetime
- 1995-12-18 DE DE59504097T patent/DE59504097D1/de not_active Expired - Lifetime
- 1995-12-18 EP EP95942687A patent/EP0792145B1/de not_active Expired - Lifetime
- 1995-12-18 AU AU43871/96A patent/AU4387196A/en not_active Abandoned
- 1995-12-19 IL IL11645295A patent/IL116452A0/xx unknown
- 1995-12-21 ZA ZA9510876A patent/ZA9510876B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE4446600A1 (de) | 1996-06-27 |
EP0792145B1 (de) | 1998-10-28 |
EP0792145A1 (de) | 1997-09-03 |
AU4387196A (en) | 1996-07-19 |
US6264980B1 (en) | 2001-07-24 |
ATE172640T1 (de) | 1998-11-15 |
IL116452A0 (en) | 1996-03-31 |
JPH10512551A (ja) | 1998-12-02 |
WO1996019975A1 (de) | 1996-07-04 |
DE59504097D1 (de) | 1998-12-03 |
SI0792145T1 (en) | 1999-10-31 |
DK0792145T3 (da) | 1999-07-12 |
JP3549207B2 (ja) | 2004-08-04 |
ZA9510876B (en) | 1996-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2125678T3 (es) | Resorcion transdermal de sustancias activas de masas fundidas subenfriadas. | |
SE9301171D0 (sv) | Pharmaceutical composition containing lipophilic drugs | |
DK0947584T3 (da) | Loxoprofen-indeholdende præparat til udvortes brug | |
DE69421689D1 (de) | Vorrichtung zur in-line verabreichung von drogen | |
AU627845B2 (en) | Improvements in or relating to devices for administration of drugs or the like | |
BR9608956A (pt) | Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto | |
PT100973A (pt) | Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica | |
MX9202804A (es) | Composicion farmaceutica y terapeutica que comprende una nueva molecula de adhesion intracelular. | |
ZA963413B (en) | Use of retinoids in a cosmetic composition or for the manufacture of a pharmaceutical composition | |
ATE210983T1 (de) | Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum | |
BR9608908A (pt) | Composto composição farmacêutica processos para aliviar dor e para preparar um composto | |
HK1000283A1 (en) | New derivatives of non-steroidal anti-inflammatory anaggesic and/or antipyretic substances their use and pharmaceutical formulations containg them | |
SG50453A1 (en) | Use of retinoids for reversing glucocorticoid induced skin atrophy | |
ITMI940884A0 (it) | Medicamento topico ad attivita' cicatrizzante | |
ZA96795B (en) | An administration form for the release of collagenase to wounds and a process for its production | |
EE9700166A (et) | Melatoniini kasutamine ravimi tootmiseks | |
IT1231342B (it) | Derivati peptidici farmacologicamente attivi e preparazioni farmaceutiche che li contengono | |
DE68905076D1 (de) | Pharmazeutische zusammensetzung fuer die behandlung von hautwunden. | |
ES2105672T3 (es) | (s)-malato de (s)-alfa-fenil-2-piridinetanamina y su utilizacion como medicamento. | |
ZA944281B (en) | Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease | |
MX9301626A (es) | Procedimientos e intermediearios para la preparacion de benzaldehidos-2-substitiudos. | |
PT101460A (pt) | Forma purificada de estreptograminas, sua preparacao e composicoes farmaceuticas que a contaem | |
ES2146683T3 (es) | Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos. | |
FR2735694B1 (fr) | Le cladinose a titre de medicament et les compositions pharmaceutiques les renfermant | |
FR2689764B1 (fr) | Utilisation de dérivés de peptides pour la fabrication de médicaments inhibiteurs des endopeptidases 24.15 et 24.16. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 792145 Country of ref document: ES |